<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
58394-051-05
</NDCCode>
<PackageDescription>
95.5 L in 1 CONTAINER (58394-051-05)
</PackageDescription>
<NDC11Code>
58394-0051-05
</NDC11Code>
<ProductNDC>
58394-051
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Adalimumab
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20190919
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
</LabelerName>
<SubstanceName>
ADALIMUMAB
</SubstanceName>
<StrengthNumber>
95.5
</StrengthNumber>
<StrengthUnit>
kg/95.5L
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2021-09-22
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20221231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
19-SEP-19
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>